Company profile: PathogenDx
1.1 - Company Overview
Company description
- Provider of RT-PCR and DNA microarray-based pathogen detection solutions, including assays for SARS-CoV-2 genes and variants (DetectX-Rv, DetectX-Cv), environmental SARS-CoV-2 screening (EnviroX-Rv), a UTI panel detecting 26 pathogens and 12 antibiotic resistance markers (D3 Array-UTI), and semi-quantitative fungal and bacterial assays (QuantX Fungal, QuantX Bacterial).
Products and services
- D3 Array-UTI: A multiplexed PCR nucleic acid assay detecting 26 pathogens and 12 antibiotic resistance markers for urinary tract infections, providing consolidated pathogen identification and resistance characterization in one test
- QuantX Bacterial: A semi-quantitative assay combining analysis of four broad class indicators plus species-specific detection within each broad class, enabling hierarchical bacterial categorization alongside organism-level identification
- QuantX Fungal: A semi-quantitative assay for fungal species in total yeast and mold, delivering actionable results in a single shift for rapid organism assessment
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to PathogenDx
Amnis
HQ: United States
Website
- Description: Provider of flow cytometry products and services used in research and clinical studies, including investigating the immune system in fighting cancer, diagnosing leukemia and lymphoma, and detecting minimal residual disease in organ transplant. Offers Cytek Aurora spectral cytometer, Aurora CS cell sorter, Northern Lights, Orion reagent prep, ESP Detection Option, and Cytek Amnis AI v3.0 image analysis software.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Amnis company profile →
Cryoniss
HQ: United Kingdom
Website
- Description: Provider of temperature-controlled biobanking and cold-chain logistics for life sciences, offering regulated storage of human biological samples at vapour phase liquid nitrogen, -80°C, -20°C, +4°C and ambient; cell banking and culture with next-day dispatch; bioreagents storage with cloud-based traceability; cell line QC testing via preferred suppliers; end-to-end sample transport; and access to samples for research.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cryoniss company profile →
Anterios
HQ: United States
Website
- Description: Provider of botulinum-based prescription products for aesthetic medicine and dermatology and nanotechnology-based delivery systems for administering drugs and cosmetics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Anterios company profile →
Repligen
HQ: United States
Website
- Description: Provider of consumable bioprocessing products and systems for manufacturing biological drugs, including KrosFlo TFF systems for ultrafiltration, diafiltration and microfiltration; XCell ATF cell-retention systems, available in single-use or stainless steel formats; NGL COVID-19 spike protein affinity resin; CTech FlowVPX in-line spectrophotometry for GMP testing; ProConnex single-use flow paths; and fluid storage and transfer solutions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Repligen company profile →
Gyros Protein Technologies
HQ: United States
Website
- Description: Provider of peptide synthesizers, reagents, and bioanalysis platforms for universities, biotechnology and pharmaceutical companies, and peptide houses. Offers automated peptide synthesis systems for discovery to pre-clinical studies, Gyrolab systems for high-throughput immunoassays for impurity analysis and titer quantification, PurePep EasyClean kits for catch-and-release peptide purification, and IQ/OQ services for compliant installation and operation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Gyros Protein Technologies company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for PathogenDx
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to PathogenDx
2.2 - Growth funds investing in similar companies to PathogenDx
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for PathogenDx
4.2 - Public trading comparable groups for PathogenDx
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →